Comment & Response |

Harmful Effects of Proton Pump Inhibitors: Discrepancies Between Observational Studies and Randomized Clinical Trials—Reply

Marcello Maggio, MD, PhD1,2; Andrea Corsonello, MD3
[+] Author Affiliations
1Section of Geriatrics, Department of Clinical and Experimental Medicine, University Hospital of Parma, Parma, Italy
2Geriatric Rehabilitation Department, University Hospital of Parma, Parma, Italy
3Unit of Geriatric Pharmacoepidemiology, Italian National Research Centres on Aging (INRCA), Cosenza, Italy
JAMA Intern Med. 2013;173(16):1559-1560. doi:10.1001/jamainternmed.2013.8459.
Text Size: A A A
Published online


In Reply We are grateful to Lalmohamed and coworkers for their constructive criticisms to our study.1 We are aware of the differences existing between data on proton pump inhibitors from randomized clinical trials/meta-analyses and those obtained from observational studies. We completely agree that the residual confounding is a relevant issue in the latter. Indeed, we extensively acknowledged this limitation in our study. We also agree that confounders not included in the analysis, such as alcohol consumption and use of systemic steroids, could also have affected the results. In our study, 14 of 491 patients (2.9%) reported a daily alcohol consumption exceeding half a liter of wine, and 47 (9.6%) had a systemic steroid prescribed at discharge. However, after adjusting for these 2 additional covariates, the association between use of proton pump inhibitors and mortality was substantially unaffected (hazard ratio, 1.55; 95% CI, 1.02-2.83) (P = .04).


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





September 9, 2013
Arief Lalmohamed, PharmD; Niels Vermeer, PharmD; Frank de Vries, PharmD, PhD
1Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, the Netherlands
2Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands
3Department of Clinical Pharmacy & Toxicology, Maastricht University Medical Centre, Maastricht, the Netherlands
JAMA Intern Med. 2013;173(16):1559. doi:10.1001/jamainternmed.2013.8468.
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Related Topics